Biophytis

Biophytis is a biotechnology company specializing in the development of drug candidates for age-related diseases. Leveraging its proprietary technology, Biophytis has initiated clinical development of innovative therapies to address unmet medical needs related to the restoration of muscle and visual functions.The company currently has two drug candidates advancing to mid-stage clinical trials: Sarconeos (BIO101) for the treatment of sarcopenic obesity, and Macuneos (BIO201) for the treatment of dry age-related macular degeneration (AMD).